Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Acadia Pharmaceuticals, Inc. (NQ: ACAD)
13.27 USD  +0.26 (+2.00%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Acadia Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 Next >
Critical Alerts For Chevron, MGM Mirage, Charter Communications, Quanta Services, and Acadia Released By InvestorsObserver
May 16, 2013
from PR Newswire
Perfect Trade Setups, How to Play CLF, AUY, ACAD and DELL
May 16, 2013
from Marketwired News Releases
ACADIA Pharmaceuticals Prices Public Offering of Common Stock
May 15, 2013
from Business Wire News Releases
ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 14, 2013
from Business Wire News Releases
Semi-Annual Changes to the NASDAQ Biotechnology Index
May 13, 2013
from GlobeNewswire News Releases
Faruqi & Faruqi, LLP Launches An Investigation Against ACADIA Pharmaceuticals Inc. (ACAD) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors
May 10, 2013
from Business Wire News Releases
ACADIA Pharmaceuticals Reports First Quarter 2013 Financial Results
May 07, 2013
from Business Wire News Releases
ACADIA Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 7, 2013
April 30, 2013
from Business Wire News Releases
ACADIA Pharmaceuticals to Present at the 12th Annual Needham Healthcare Conference on April 30, 2013
April 25, 2013
from Business Wire News Releases
Earnings Forecast Spotlight for Hewlett-Packard, ACADIA Pharmaceuticals, EMC, NVIDIA, MetroPCS, and AT&T
April 12, 2013
from PR Newswire
Free Research Reports on ACAD, BBBY, SSH and YUM Issued by the Paragon Report
April 12, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
GOFF Corporation Shares Halt The Slide Looking For Follow Through- Top Five Small Cap Stocks Ahead Of The Bell: Lyon Williams, Acadia Pharmaceutical, Fannie Mae, AMR Corporation
April 12, 2013
from PR Newswire
Retailers Push Stocks Higher and Pfizer Inc. hits a new 52-Week High
April 12, 2013
from PR Newswire
Inta-day Gainers On The Current Trading Session: (NYSE: BYD), (NASDAQ: ACAD)
April 11, 2013
from SBWire Direct - Latest Press Releases
ACADIA Pharmaceuticals Announces Expedited Path to NDA Filing for Pimavanserin Following Meeting with FDA
April 11, 2013
from Business Wire News Releases
Over $400 Million Raised by U.S. Life Sciences Companies Through At-the-Market (ATM) Offerings in 2012, Reports Brinson Patrick
April 08, 2013
- Record High Usage of ATMs in 2012 by U.S. Life Sciences Companies - Read More
from PR Newswire
Pre-Market Analysis on Dendreon, ACADIA Pharma, Medivation, and Cell Therapeutics
April 05, 2013
from PR Newswire
Acadia Pharmaceuticals&ON Semiconductor Trend Analysis Reports: (NASDAQ: ACAD), (NASDAQ: ONNN)
March 25, 2013
from SBWire Direct - Latest Press Releases
Morning Movers - StereotaxisInc, Veeco Instruments Inc, ACADIA Pharmaceuticals Inc, Array BiopharmaInc
March 25, 2013
from SBWire Direct - Latest Press Releases
Apple Shares Bounce on Rumored iPhone 5S
March 22, 2013
from PR Newswire
ACADIA Pharmaceuticals Inc. & SUPERVALU Inc. Announcements: (NASDAQ: ACAD), (NYSE: SVU)
March 22, 2013
from SBWire Direct - Latest Press Releases
Free Research Reports on ACAD, ANAC, AFFY and DNN Issued by the Bedford Report
March 22, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Insider Trading Update: AT&T, Ford Motor, Cliffs Natural Resources, ACADIA Pharmaceuticals, Best Buy, and SUPERVALU
March 22, 2013
from PR Newswire
Morning Winners - Affymax, Inc. (NASDAQ:AFFY), ACADIA Pharmaceuticals Inc, SUPERVALU INC, ISIS Pharmaceuticals Inc
March 21, 2013
from SBWire Direct - Latest Press Releases
ACADIA Announces Presentation of Data from Its Pivotal Phase III Parkinson’s Disease Psychosis Study with Pimavanserin at the American Academy of Neurology Annual Meeting
March 20, 2013
from Business Wire News Releases
FDA's New "Breakthrough" Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing
March 15, 2013
Five Star Equities Provides Stock Research on ACADIA Pharmaceuticals and BioCryst Pharmaceuticals Read More
from Marketwired News Releases
ACADIA Pharmaceuticals to Present at the 25th Annual ROTH Conference on March 19, 2013
March 13, 2013
from Business Wire News Releases
ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
March 12, 2013
from Business Wire News Releases
Today's Research on PDL BioPharma, Dendreon, Medivation, ACADIA Pharma, and Cell Therapeutics
March 06, 2013
from PR Newswire
ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2012 Financial Results on March 12, 2013
March 05, 2013
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here